Evaluation of a Computerized Decision Support Intervention to Decrease Use of Anti-Pseudomonal Carbapenems in

Christina Caplinger1, Garret Smith2, Richard Remington3

  • 1Infectious Diseases Research Fellow, Pharmacy Service, Boise Veterans Affairs Medical Center, Bldg T111, 500 W Fort St. Boise, ID 83702, USA. Christina.caplinger@va.gov.

Insights

A computerized decision support system (CDSS) intervention reduced the prescribing of antipseudomonal carbapenems (APC) in patients with beta-lactam allergy history. This change improved appropriate antibiotic selection without adverse events, demonstrating effective clinical decision support.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacy
  • Health Informatics

Background:

  • Beta-lactam antibiotic allergies are frequently reported but often lack true hypersensitivity.
  • Cross-reactivity with advanced cephalosporins and carbapenems is low, especially in patients without type 1 hypersensitivity.
  • Clinicians often overprescribe antipseudomonal carbapenems (APC) for patients with beta-lactam allergy history, even in low-risk scenarios.

Purpose of the Study:

  • To evaluate the impact of a computerized decision support system (CDSS) intervention on APC prescribing patterns.
  • To assess if the CDSS improved the selection of appropriate antibiotics for patients with beta-lactam allergy history.
  • To determine if the intervention reduced APC use, particularly in low-risk patients.

Main Methods:

  • A retrospective evaluation was conducted in a hospital setting.
  • Computerized decision support system (CDSS) changes were implemented to guide beta-lactam cross-reactivity risk assessment and therapy selection.
  • Antipseudomonal carbapenem (APC) initiations were measured per 1000 patient-days before and after the intervention.
  • Interrupted time-series analysis was used to assess changes in APC prescribing trends.

Main Results:

  • Aggregate monthly APC initiations decreased significantly from 7.01 to 6.14 per 1000 patient-days post-intervention (p = 0.03).
  • APC initiations for low-risk beta-lactam history patients decreased from 92% to 83% (p = 0.17), though not statistically significant.
  • No adverse events were observed in patients with low-risk beta-lactam histories during the study period.

Conclusions:

  • The CDSS intervention was associated with a reduction in overall APC initiations.
  • The findings suggest that CDSS can effectively guide clinicians towards more appropriate antibiotic selection in beta-lactam allergy cases.
  • Further studies may be needed to confirm the impact on low-risk patient prescribing and to assess long-term effects.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
21
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.3K
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
11
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
618
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
63
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
47